abstract |
PROBLEM TO BE SOLVED: To provide a prognostic marker, a prognostic signature, a composition and a method for determining the prognosis of cancer, particularly melanoma, in a patient. A prognostic signature for determining the risk of melanoma progression, including two or more melanoma prognostic markers (MPMs), a substrate having one or more locations on the surface, each location having 2 there. A device for determining the prognosis of melanoma, and a method for determining the suitability of a melanoma patient for a drug test, having one or more oligonucleotides, each oligonucleotide being selected from one or more MPMs. [Selection diagram] None |